Drug Trial Radar · NCT05270044
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Last checked: Nov 19, 2026Latest source record: Nov 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
815
Planned (sponsor's estimate)
Start
May 2, 2022
Primary completion
Mar 31, 2027
Study completion May 2, 2035
Sponsor
- Lead sponsor
- Pierre Fabre MedicamentIndustry
- Sponsor type
- Industry
- Collaborators
- European Organisation for Research and Treatment of Cancer - EORTC
- First posted
- Mar 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the Columbus-AD study is to evaluate the efficacy and safety of 12 months of encorafenib in combination with binimetinib in adjuvant setting of BRAF V600E/K mutant stage IIB/C melanoma versus the current standard of care (surveillance).
Conditions
- Melanoma
Interventions
Encorafenib and BinimetinibDrug
Encorafenib 450 mg (6 × 75 mg capsules) once daily (QD) and binimetinib 45 mg (3 x 15 mg tablets) twice daily (BID) orally for a maximum of 12 months.
Placebo to match Encorafenib ; Placebo to match BinimetinibDrug
Encorafenib (6 × 75 mg placebo capsules) QD and binimetinib (3 × 15 mg placebo tablets) BID placebos orally for a maximum of 12 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recurrence-free survival (RFS)Time frame: Approximately 4.4 years from the accrual of the first patient.
Locations
155 sites in 23 countries. Site status is shown where the registry gives one.
Hospital Aleman
Ciudad Autonoma Buenos Aires, Argentina
Instituto Medico Especializado Alexander Fleming
Ciudad Autonoma Buenos Aires, Argentina
Clinica Adventista Belgrano
Ciudad Autonoma Buenos Aires, Argentina
Centro Oncologico Korben
CABA, Buenos Aires, Argentina
Centro de Investigaciones Medicas Mar del Plata
Mar del Plata, Buenos Aires, Argentina
Fundacion CIDEA
Ciudad Autonoma Bs As, Ciudad Autonoma Buenos Aires, Argentina
Sanatorio Britanico S.A.
Rosario, Santa Fe Province, Argentina
Instituto de Oncologia de Rosario
Rosario, Santa Fe Province, Argentina
Westmead Hospital
Sydney, New South Wales, Australia
Melanoma Institute Australia
Wollstonecraft, New South Wales, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Adelaide Oncology & Haematolog, Calvary North Adelaide Hospital
North Adelaide, South Australia, Australia
Box Hill Hospital
Box Hill, Victoria, Australia
Austin Health
Heidelberg, Victoria, Australia
The Alfred Hospital
Prahran, Victoria, Australia
Hollywood Private Hospital
Nedlands, Western Australia, Australia
Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
Landeskrankenhaus - Universitaetsklinikum Graz
Graz, Austria
Krankenhaus der Elisabethinen Linz
Linz, Austria
Universitätsklinikum St.Pölten-Lilienfeld
Sankt Pölten, Austria
AKH - Medizinische Universität Wien
Vienna, Austria
Institut Jules Bordet
Anderlecht, Belgium
ZNA Middelheim
Antwerp, Belgium
Universitair Ziekenhuis Brussel
Brussels, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
UZ Gent
Ghent, Belgium
ZNA
Merksem, Belgium
Vitaz
Sint-Niklaas, Belgium
CHU UCL Namur
Yvoir, Belgium
AMO - Assistência Multidisciplinar em Oncologia
Salvador, Estado de Bahia, Brazil
Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer
Curitiba, Paraná, Brazil
Instituto de Cancer de Londrina
Londrina, Paraná, Brazil
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
HGB - Hospital Giovanni Battista - Mãe de Deus Center
Porto Alegre, Rio Grande do Sul, Brazil
Instituto de Oncologia Saint Gallen
Santa Cruz do Sul, Rio Grande do Sul, Brazil
CEPON - Centro de Pesquisas Oncológicas de Santa Catarina
Florianópolis, Santa Catarina, Brazil
Fundação Doutor Amaral Carvalho
Jaú, São Paulo, Brazil
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia
Santo André, São Paulo, Brazil
A. C. Camargo Cancer Center
São Paulo, São Paulo, Brazil
London Health Sciences Centre (LHSC) - Victoria Hospital
London, Ontario, Canada
Showing 40 of 155 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.